Coeptis Therapeutics (COEP) Stock Chart & Stock Price History → Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad) Free COEP Stock Alerts $0.28 +0.01 (+3.69%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Coeptis Therapeutics Stock Price Performance5 Day Performance+6.40%1 Month Performance-23.25%3 Month Performance-41.48%6 Month Performance-72.99%Year-To-Date Performance-64.17%1 Year Performance-81.58% Receive COEP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Market Moving TrendsTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Click to View The 5 Best AI Stocks to Invest In COEP Stock Chart for Sunday, June, 9, 2024 COEP Chart by TradingView Coeptis Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$0.27$0.28+5.01%$0.29$0.26200,677 shs$10.43 million06/06/2024$0.30$0.27-9.54%$0.30$0.23487,595 shs$9.93 million06/05/2024$0.26$0.30+12.01%$0.30$0.26759,668 shs$10.98 million06/04/2024$0.27$0.26-3.54%$0.28$0.26150,678 shs$9.80 million06/03/2024$0.27$0.27+1.22%$0.28$0.2697,407 shs$10.16 million05/31/2024$0.27$0.27-0.33%$0.28$0.26123,249 shs$10.04 million Get the Latest News and Ratings for COEP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$0.26$0.27+4.75%$0.29$0.26493,030 shs$10.07 million05/29/2024$0.27$0.26-2.63%$0.27$0.25475,918 shs$9.61 million05/28/2024$0.29$0.27-7.54%$0.30$0.27351,554 shs$9.87 million05/27/2024$0.29$0.29$0.29$0.26801,600 shs$10.68 million05/24/2024$0.26$0.29+10.19%$0.29$0.26720,391 shs$10.68 million05/23/2024$0.30$0.26-13.37%$0.30$0.261.78 million shs$9.69 million05/22/2024$0.34$0.30-10.56%$0.33$0.2815.95 million shs$11.19 million05/21/2024$0.33$0.34+1.32%$0.36$0.3243,880 shs$12.51 million05/20/2024$0.35$0.33-5.00%$0.36$0.33109,312 shs$12.35 million05/17/2024$0.36$0.35-1.46%$0.38$0.3534,552 shs$13.00 million05/16/2024$0.36$0.36+0.08%$0.37$0.3673,874 shs$13.19 million05/15/2024$0.36$0.36-2.07%$0.37$0.3562,296 shs$13.18 million05/14/2024$0.36$0.36+1.48%$0.37$0.3547,498 shs$13.08 million05/13/2024$0.38$0.36-6.78%$0.39$0.30174,971 shs$12.89 million05/10/2024$0.37$0.38+4.70%$0.39$0.3863,976 shs$13.83 million05/09/2024$0.38$0.37-3.68%$0.39$0.3669,492 shs$13.21 million05/08/2024$0.38$0.38+1.33%$0.39$0.3779,187 shs$13.71 million05/07/2024$0.36$0.38+4.17%$0.42$0.35183,289 shs$13.53 million05/06/2024$0.36$0.36$0.38$0.3626,797 shs$12.99 million05/03/2024$0.37$0.36-2.60%$0.41$0.36316,082 shs$12.99 million05/02/2024$0.34$0.37+8.77%$0.38$0.33377,365 shs$13.34 million05/01/2024$0.31$0.34+9.12%$0.34$0.3279,866 shs$12.26 million04/30/2024$0.33$0.31-7.02%$0.32$0.31202,006 shs$11.24 million04/29/2024$0.33$0.33+0.03%$0.34$0.3293,836 shs$12.09 million04/26/2024$0.32$0.33+3.98%$0.35$0.3252,491 shs$12.08 million04/25/2024$0.33$0.32-1.53%$0.34$0.3269,033 shs$11.62 million04/24/2024$0.34$0.33-2.39%$0.35$0.32148,061 shs$11.80 million04/23/2024$0.35$0.34-3.18%$0.35$0.3351,060 shs$12.09 million04/22/2024$0.33$0.35+4.53%$0.38$0.3288,989 shs$12.49 million04/19/2024$0.35$0.33-6.71%$0.38$0.32188,390 shs$11.95 million04/18/2024$0.37$0.35-3.19%$0.37$0.3550,856 shs$12.81 million04/17/2024$0.37$0.37+0.30%$0.38$0.3681,002 shs$13.23 million04/16/2024$0.37$0.37-0.57%$0.39$0.3576,665 shs$13.19 million04/15/2024$0.42$0.37-12.21%$0.43$0.33415,911 shs$13.26 millionBreaking - The US Gov. Seized CITGO (Ad)Do you want an investment that can double or triple your money in the next three months? The US Court is currently auctioning off CITGO (the winning bid will be announced on July 22nd).Get all the details here.04/12/2024$0.43$0.42-3.14%$0.43$0.40234,947 shs$15.02 million04/11/2024$0.39$0.43+10.15%$0.48$0.401.60 million shs$15.50 million04/10/2024$0.39$0.39+0.26%$0.39$0.37138,928 shs$14.08 million04/09/2024$0.35$0.39+11.11%$0.41$0.36307,385 shs$14.04 million04/08/2024$0.32$0.35+8.29%$0.37$0.32524,426 shs$12.64 million04/05/2024$0.33$0.32-1.91%$0.34$0.31134,858 shs$11.67 million04/04/2024$0.31$0.33+4.77%$0.33$0.32145,584 shs$11.90 million04/03/2024$0.31$0.31-0.03%$0.33$0.31226,367 shs$11.35 million04/02/2024$0.30$0.31+6.68%$0.36$0.30931,734 shs$11.36 million04/01/2024$0.30$0.30-0.81%$0.32$0.29135,830 shs$10.65 million03/29/2024$0.30$0.30$0.30$0.29159,881 shs$10.73 million03/28/2024$0.30$0.30+0.13%$0.30$0.29157,269 shs$10.14 million03/27/2024$0.30$0.30-1.00%$0.31$0.29102,358 shs$10.13 million03/26/2024$0.31$0.30-2.44%$0.31$0.29121,535 shs$10.23 million03/25/2024$0.31$0.31-2.07%$0.33$0.30180,435 shs$10.49 million03/22/2024$0.32$0.31-0.63%$0.33$0.30167,708 shs$10.71 million03/21/2024$0.32$0.32-2.47%$0.34$0.31264,263 shs$10.78 million03/20/2024$0.31$0.32+5.47%$0.33$0.30222,602 shs$11.05 million03/19/2024$0.32$0.31-4.54%$0.36$0.31206,934 shs$10.48 million03/18/2024$0.36$0.32-10.44%$0.38$0.32274,645 shs$10.98 million03/15/2024$0.37$0.36-3.93%$0.39$0.35166,498 shs$12.26 million03/14/2024$0.39$0.37-4.10%$0.42$0.3671,151 shs$12.76 million03/13/2024$0.43$0.39-8.24%$0.43$0.38148,398 shs$13.30 million03/12/2024$0.44$0.43-2.52%$0.45$0.4176,472 shs$14.50 million03/11/2024$0.48$0.44-9.17%$0.48$0.43189,998 shs$14.87 million03/08/2024$0.50$0.48-3.85%$0.50$0.47101,606 shs$16.37 million Related Companies: OKYO Pharma Stock Price Chart Achilles Therapeutics Stock Price Chart Cyclo Therapeutics Stock Price Chart Quince Therapeutics Stock Price Chart Surrozen Stock Price Chart Estrella Immunopharma Stock Price Chart Brainstorm Cell Therapeutics Stock Price Chart MiNK Therapeutics Stock Price Chart Pluri Stock Price Chart Cortexyme Stock Price Chart Receive COEP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coeptis Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:COEP) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.